{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:28:56Z","timestamp":1744172936385,"version":"3.40.3"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,2,6]],"date-time":"2015-02-06T00:00:00Z","timestamp":1423180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,2,6]],"date-time":"2015-02-06T00:00:00Z","timestamp":1423180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s00262-015-1659-7","type":"journal-article","created":{"date-parts":[[2015,2,5]],"date-time":"2015-02-05T06:45:51Z","timestamp":1423118751000},"page":"479-491","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Strengthened tumor antigen immune recognition by inclusion of a recombinant Eimeria antigen in therapeutic cancer vaccination"],"prefix":"10.1007","volume":"64","author":[{"given":"Dionisia","family":"Quiroga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasser A.","family":"Aldhamen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel M.","family":"Appledorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Godbehere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Amalfitano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,6]]},"reference":[{"key":"1659_CR1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1001294","volume":"363","author":"PW Kantoff","year":"2010","unstructured":"Kantoff PW, Higano CS, Shore ND et al (2010) Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med 363:411\u2013422. doi:10.1056\/NEJMoa1001294","journal-title":"N Engl J Med"},{"key":"1659_CR2","doi-asserted-by":"publisher","first-page":"5323","DOI":"10.1158\/1078-0432.CCR-09-0737","volume":"15","author":"MA Cheever","year":"2009","unstructured":"Cheever MA, Allison JP, Ferris AS et al (2009) The prioritization of cancer antigens: a National Cancer Institute Pilot Project for the acceleration of translational research. Clin Cancer Res 15:5323\u20135337. doi:10.1158\/1078-0432.CCR-09-0737","journal-title":"Clin Cancer Res"},{"key":"1659_CR3","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1200\/JCO.2005.10.206","volume":"23","author":"JL Marshall","year":"2005","unstructured":"Marshall JL, Gulley JL, Arlen PM et al (2005) Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomas. J Clin Oncol 23:720\u2013731. doi:10.1200\/JCO.2005.10.206","journal-title":"J Clin Oncol"},{"key":"1659_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00262-013-1505-8","volume":"63","author":"M Bilusic","year":"2014","unstructured":"Bilusic M, Heery CR, Arlen PM et al (2014) Phase I trial of a recombinant yeast-CEA vaccine (GI-6207) in adults with metastatic CEA-expressing carcinoma. Cancer Immunol Immunother 63:225\u2013234. doi:10.1007\/s00262-013-1505-8","journal-title":"Cancer Immunol Immunother"},{"key":"1659_CR5","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1158\/1078-0432.CCR-04-2172","volume":"11","author":"MA Morse","year":"2005","unstructured":"Morse MA, Clay TM, Hobeika AC et al (2005) Phase I study of immunization with dendritic cells modified with fowlpox encoding carcinoembryonic antigen and costimulatory molecules. Clin Cancer Res 11:3017\u20133024. doi:10.1158\/1078-0432.CCR-04-2172","journal-title":"Clin Cancer Res"},{"key":"1659_CR6","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1158\/1078-0432.CCR-03-0706","volume":"10","author":"GJ Ullenhag","year":"2004","unstructured":"Ullenhag GJ, Fr\u00f6din J-E, Jeddi-Tehrani M et al (2004) Durable carcinoembryonic antigen (CEA)-specific humoral and cellular immune responses in colorectal carcinoma patients vaccinated with recombinant CEA and granulocyte\/macrophage colony-stimulating factor. Clin Cancer Res 10:3273\u20133281. doi:10.1158\/1078-0432.CCR-03-0706","journal-title":"Clin Cancer Res"},{"key":"1659_CR7","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s00262-010-0847-8","volume":"59","author":"E Gabitzsch","year":"2010","unstructured":"Gabitzsch E, Xu Y, Balint J et al (2010) Anti-tumor immunotherapy despite immunity to adenovirus using a novel adenoviral vector Ad5 [E1-, E2b-]-CEA. Cancer Immunol Immunother 59:1131\u20131135. doi:10.1007\/s00262-010-0847-8","journal-title":"Cancer Immunol Immunother"},{"key":"1659_CR8","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s00262-013-1400-3","volume":"62","author":"MA Morse","year":"2013","unstructured":"Morse MA, Chaudhry A, Gabitzsch ES et al (2013) Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients. Cancer Immunol Immunother 62:1293\u20131301. doi:10.1007\/s00262-013-1400-3","journal-title":"Cancer Immunol Immunother"},{"key":"1659_CR9","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0140-6736(12)61900-X","volume":"381","author":"A Grothey","year":"2013","unstructured":"Grothey A, Van Cutsem E, Sobrero A et al (2013) Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet 381:303\u2013312. doi:10.1016\/S0140-6736(12)61900-X","journal-title":"Lancet"},{"key":"1659_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4049\/jimmunol.181.1.155","volume":"181","author":"MY Gerner","year":"2008","unstructured":"Gerner MY, Casey KA, Mescher MF (2008) Defective MHC class II presentation by dendritic cells limits CD4 T cell help for antitumor CD8 T cell responses. J Immunol 181:155\u2013164. doi:10.4049\/jimmunol.181.1.155","journal-title":"J Immunol"},{"key":"1659_CR11","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1007\/s00262-008-0487-4","volume":"57","author":"P Stoitzner","year":"2008","unstructured":"Stoitzner P, Green LK, Jung JY et al (2008) Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells. Cancer Immunol Immunother 57:1665\u20131673. doi:10.1007\/s00262-008-0487-4","journal-title":"Cancer Immunol Immunother"},{"key":"1659_CR12","doi-asserted-by":"publisher","first-page":"7209","DOI":"10.1158\/0008-5472.CAN-10-0905","volume":"70","author":"ZC Hartman","year":"2010","unstructured":"Hartman ZC, Osada T, Glass O et al (2010) Ligand-independent toll-like receptor signals generated by ectopic overexpression of MyD88 generate local and systemic antitumor immunity. Cancer Res 70:7209\u20137220. doi:10.1158\/0008-5472.CAN-10-0905","journal-title":"Cancer Res"},{"key":"1659_CR13","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/ni1059","volume":"5","author":"Y Yang","year":"2004","unstructured":"Yang Y, Huang C-T, Huang X, Pardoll DM (2004) Persistent toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance. Nat Immunol 5:508\u2013515. doi:10.1038\/ni1059","journal-title":"Nat Immunol"},{"issue":"Suppl 3","key":"1659_CR14","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1016\/S0264-410X(02)00168-8","volume":"20","author":"CJ Clements","year":"2002","unstructured":"Clements CJ, Griffiths E (2002) The global impact of vaccines containing aluminium adjuvants. Vaccine 20(Suppl 3):S24\u2013S33. doi:10.1016\/S0264-410X(02)00168-8","journal-title":"Vaccine"},{"key":"1659_CR15","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1084\/jem.20052433","volume":"203","author":"U Wille-Reece","year":"2006","unstructured":"Wille-Reece U, Flynn BJ, Lor\u00e9 K et al (2006) Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates. J Exp Med 203:1249\u20131258. doi:10.1084\/jem.20052433","journal-title":"J Exp Med"},{"key":"1659_CR16","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10875-007-9087-x","volume":"27","author":"KJ Ishii","year":"2007","unstructured":"Ishii KJ, Akira S (2007) Toll or toll-free adjuvant path toward the optimal vaccine development. J Clin Immunol 27:363\u2013371. doi:10.1007\/s10875-007-9087-x","journal-title":"J Clin Immunol"},{"key":"1659_CR17","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/ijc.20801","volume":"114","author":"B Rosenberg","year":"2005","unstructured":"Rosenberg B, Juckett DA, Aylsworth CF et al (2005) Protein from intestinal Eimeria protozoan stimulates IL-12 release from dendritic cells, exhibits antitumor properties in vivo and is correlated with low intestinal tumorigenicity. Int J Cancer 114:756\u2013765. doi:10.1002\/ijc.20801","journal-title":"Int J Cancer"},{"key":"1659_CR18","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1158\/1078-0432.CCR-07-4250","volume":"14","author":"JS Rader","year":"2008","unstructured":"Rader JS, Aylsworth CF, Juckett DA et al (2008) Phase I study and preliminary pharmacology of the novel innate immune modulator rBBX-01 in gynecologic cancers. Clin Cancer Res 14:3089\u20133097. doi:10.1158\/1078-0432.CCR-07-4250","journal-title":"Clin Cancer Res"},{"key":"1659_CR19","doi-asserted-by":"publisher","first-page":"e9579","DOI":"10.1371\/journal.pone.0009579","volume":"5","author":"DM Appledorn","year":"2010","unstructured":"Appledorn DM, Aldhamen YA, Depas W et al (2010) A new adenovirus based vaccine vector expressing an Eimeria tenella derived TLR agonist improves cellular immune responses to an antigenic target. PLoS One 5:e9579. doi:10.1371\/journal.pone.0009579","journal-title":"PLoS One"},{"key":"1659_CR20","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.humimm.2013.04.035","volume":"74","author":"CF Aylsworth","year":"2013","unstructured":"Aylsworth CF, Aldhamen YA, Seregin SS et al (2013) Activation of human natural killer cells by the novel innate immune modulator recombinant Eimeria antigen. Hum Immunol 74:916\u2013926. doi:10.1016\/j.humimm.2013.04.035","journal-title":"Hum Immunol"},{"key":"1659_CR21","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","volume":"95","author":"T-C He","year":"1998","unstructured":"He T-C, Zhou S, da Costa LT et al (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci 95:2509\u20132514. doi:10.1073\/pnas.95.5.2509","journal-title":"Proc Natl Acad Sci"},{"key":"1659_CR22","doi-asserted-by":"publisher","first-page":"e24147","DOI":"10.1371\/journal.pone.0024147","volume":"6","author":"NJ Schuldt","year":"2011","unstructured":"Schuldt NJ, Aldhamen YA, Appledorn DM et al (2011) Vaccine platforms combining circumsporozoite protein and potent immune modulators, rEA or EAT-2, paradoxically result in opposing immune responses. PLoS One 6:e24147. doi:10.1371\/journal.pone.0024147","journal-title":"PLoS One"},{"key":"1659_CR23","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1172\/JCI42672","volume":"120","author":"MA Morse","year":"2010","unstructured":"Morse MA, Hobeika AC, Osada T et al (2010) An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer. J Clin Invest 120:3234\u20133241. doi:10.1172\/JCI42672","journal-title":"J Clin Invest"},{"key":"1659_CR24","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1385\/1-59259-141-8:389","volume":"69","author":"P Ng","year":"2002","unstructured":"Ng P, Graham FL (2002) Construction of first-generation adenoviral vectors. Methods Mol Med 69:389\u2013414. doi:10.1385\/1-59259-141-8:389","journal-title":"Methods Mol Med"},{"key":"1659_CR25","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/mt.2008.297","volume":"17","author":"SS Seregin","year":"2009","unstructured":"Seregin SS, Appledorn DM, McBride AJ et al (2009) Transient pretreatment with glucocorticoid ablates innate toxicity of systemically delivered adenoviral vectors without reducing efficacy. Mol Ther 17:685\u2013696. doi:10.1038\/mt.2008.297","journal-title":"Mol Ther"},{"key":"1659_CR26","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.4049\/jimmunol.181.3.2134","volume":"181","author":"DM Appledorn","year":"2008","unstructured":"Appledorn DM, Patial S, McBride A et al (2008) Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo. J Immunol 181:2134\u20132144. doi:10.4049\/jimmunol.181.3.2134","journal-title":"J Immunol"},{"key":"1659_CR27","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/cgt.2013.53","volume":"20","author":"YA Aldhamen","year":"2013","unstructured":"Aldhamen YA, Seregin SS, Kousa YA et al (2013) Improved cytotoxic T-lymphocyte immune responses to a tumor antigen by vaccines co-expressing the SLAM-associated adaptor EAT-2. Cancer Gene Ther 20:564\u2013575. doi:10.1038\/cgt.2013.53","journal-title":"Cancer Gene Ther"},{"key":"1659_CR28","doi-asserted-by":"publisher","first-page":"722","DOI":"10.4049\/jimmunol.1002105","volume":"186","author":"YA Aldhamen","year":"2011","unstructured":"Aldhamen YA, Appledorn DM, Seregin SS et al (2011) Expression of the SLAM family of receptors adapter EAT-2 as a novel strategy for enhancing beneficial immune responses to vaccine antigens. J Immunol 186:722\u2013732. doi:10.4049\/jimmunol.1002105","journal-title":"J Immunol"},{"key":"1659_CR29","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1038\/gt.2008.114","volume":"15","author":"DM Appledorn","year":"2008","unstructured":"Appledorn DM, McBride A, Seregin S et al (2008) Complex interactions with several arms of the complement system dictate innate and humoral immunity to adenoviral vectors. Gene Ther 15:1606\u20131617. doi:10.1038\/gt.2008","journal-title":"Gene Ther"},{"key":"1659_CR30","first-page":"24","volume":"6","author":"MZ Zhu","year":"2000","unstructured":"Zhu MZ, Marshall J, Cole D et al (2000) Specific cytolytic T-cell responses to human CEA from patients immunized with recombinant avipox-CEA vaccine. Clin Cancer Res 6:24\u201333","journal-title":"Clin Cancer Res"},{"key":"1659_CR31","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/mt.2010.272","volume":"19","author":"MR Parkhurst","year":"2011","unstructured":"Parkhurst MR, Yang JC, Langan RC et al (2011) T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis. Mol Ther 19:620\u2013626. doi:10.1038\/mt.2010.272","journal-title":"Mol Ther"},{"key":"1659_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0198-8859(97)00255-3","volume":"59","author":"I Kawashima","year":"1998","unstructured":"Kawashima I, Hudson SJ, Tsai V et al (1998) The multi-epitope approach for immunotherapy for cancer: identification of several CTL epitopes from various tumor-associated antigens expressed on solid epithelial tumors. Hum Immunol 59:1\u201314. doi:10.1016\/S0198-8859(97)00255-3","journal-title":"Hum Immunol"},{"key":"1659_CR33","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/eji.1830250206","volume":"25","author":"F Lehmann","year":"1995","unstructured":"Lehmann F, Marchand M, Hainaut P et al (1995) Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection. Eur J Immunol 25:340\u2013347. doi:10.1002\/eji.1830250206","journal-title":"Eur J Immunol"},{"key":"1659_CR34","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/(SICI)1097-0215(19990105)80:1<92::AID-IJC18>3.0.CO;2-M","volume":"80","author":"I Nukaya","year":"1999","unstructured":"Nukaya I, Yasumoto M, Iwasaki T et al (1999) Identification of HLA-A24 epitope peptides of carcinoembryonic antigen which induce tumor-reactive cytotoxic T lymphocyte. Int J Cancer 80:92\u201397. doi:10.1054\/bjoc.2000.1715","journal-title":"Int J Cancer"},{"key":"1659_CR35","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1158\/1078-0432.CCR-03-0476","volume":"10","author":"M Ruiz","year":"2004","unstructured":"Ruiz M, Kobayashi H, Lasarte JJ et al (2004) Identification and characterization of a T-helper peptide from carcinoembryonic antigen. Clin Cancer Res 10:2860\u20132867. doi:10.1158\/1078-0432.CCR-03-0476","journal-title":"Clin Cancer Res"},{"key":"1659_CR36","first-page":"3219","volume":"8","author":"H Kobayashi","year":"2002","unstructured":"Kobayashi H, Omiya R, Ruiz M et al (2002) Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigen. Clin Cancer Res 8:3219\u20133225","journal-title":"Clin Cancer Res"},{"key":"1659_CR37","doi-asserted-by":"publisher","first-page":"4843","DOI":"10.1158\/1078-0432.CCR-08-0276","volume":"14","author":"HL Kaufman","year":"2008","unstructured":"Kaufman HL, Lenz H-J, Marshall J et al (2008) Combination chemotherapy and ALVAC-CEA\/B7.1 vaccine in patients with metastatic colorectal cancer. Clin Cancer Res 14:4843\u20134849. doi:10.1158\/1078-0432.CCR-08-0276","journal-title":"Clin Cancer Res"},{"key":"1659_CR38","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1172\/JCI200421695","volume":"114","author":"Z Yu","year":"2004","unstructured":"Yu Z, Theoret MR, Touloukian CE et al (2004) Poor immunogenicity of a self\/tumor antigen derives from peptide-MHC-I instability and is independent of tolerance. J Clin Invest 114:551\u2013559. doi:10.1172\/JCI21695","journal-title":"J Clin Invest"},{"key":"1659_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virusres.2007.10.005","volume":"132","author":"ZC Hartman","year":"2008","unstructured":"Hartman ZC, Appledorn DM, Amalfitano A (2008) Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications. Virus Res 132:1\u201314. doi:10.1016\/j.virusres.2007.10.005","journal-title":"Virus Res"},{"key":"1659_CR40","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1038\/sj.mt.6300235","volume":"15","author":"A Br\u00e5ve","year":"2007","unstructured":"Br\u00e5ve A, Boberg A, Gudmundsdotter L et al (2007) A new multi-clade DNA prime\/recombinant MVA boost vaccine induces broad and high levels of HIV-1-specific CD8+ T-cell and humoral responses in mice. Mol Ther 15:1724\u20131733. doi:10.1038\/sj.mt.6300235","journal-title":"Mol Ther"},{"key":"1659_CR41","doi-asserted-by":"publisher","first-page":"5093","DOI":"10.4049\/jimmunol.176.8.5093","volume":"176","author":"M Crosti","year":"2006","unstructured":"Crosti M, Longhi R, Consogno G et al (2006) Identification of novel subdominant epitopes on the carcinoembryonic antigen recognized by CD4+ T cells of lung cancer patients. J Immunol 176:5093\u20135099. doi:10.4049\/jimmunol.176.8.5093","journal-title":"J Immunol"},{"key":"1659_CR42","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/2051-1426-1-8","volume":"1","author":"DM Geynisman","year":"2013","unstructured":"Geynisman DM, Zha Y, Kunnavakkam R et al (2013) A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)\/montanide\/GM-CSF-vaccine in patients with pancreatic adenocarcinoma. J Immunother Cancer 1:8. doi:10.1186\/2051-1426-1-8","journal-title":"J Immunother Cancer"},{"key":"1659_CR43","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1158\/0008-5472.CAN-13-2269","volume":"74","author":"I Peguillet","year":"2014","unstructured":"Peguillet I, Milder M, Louis D et al (2014) High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer. Cancer Res 74:2204\u20132216. doi:10.1158\/0008-5472.CAN-13-2269","journal-title":"Cancer Res"},{"key":"1659_CR44","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","volume":"33","author":"RL Coffman","year":"2010","unstructured":"Coffman RL, Sher A, Seder RA (2010) Vaccine adjuvants: putting innate immunity to work. Immunity 33:492\u2013503. doi:10.1016\/j.immuni.2010.10.002","journal-title":"Immunity"},{"key":"1659_CR45","doi-asserted-by":"publisher","first-page":"e22064","DOI":"10.1371\/journal.pone.0022064","volume":"6","author":"SS Seregin","year":"2011","unstructured":"Seregin SS, Aldhamen YA, Appledorn DM et al (2011) TRIF is a critical negative regulator of TLR agonist mediated activation of dendritic cells in vivo. PLoS One 6:e22064. doi:10.1371\/journal.pone.0022064","journal-title":"PLoS One"},{"key":"1659_CR46","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1159\/000362367","volume":"6","author":"RM Salazar Gonzalez","year":"2014","unstructured":"Salazar Gonzalez RM, Shehata H, O\u2019Connell MJ et al (2014) Toxoplasma gondii- derived profilin triggers human toll-like receptor 5-dependent cytokine production. J Innate Immun 6:685\u2013694. doi:10.1159\/000362367","journal-title":"J Innate Immun"},{"key":"1659_CR47","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1126\/science.1198687","volume":"331","author":"E Vivier","year":"2011","unstructured":"Vivier E, Raulet DH, Moretta A et al (2011) Innate or adaptive immunity? the example of natural killer cells. Science 331:44\u201349. doi:10.1126\/science.1198687","journal-title":"Science"},{"key":"1659_CR48","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1177\/09680519010070030101","volume":"7","author":"C Alexander","year":"2001","unstructured":"Alexander C, Rietschel ET (2001) Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res 7:167\u2013202. doi:10.1177\/09680519010070030101","journal-title":"J Endotoxin Res"},{"key":"1659_CR49","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1126\/science.1240527","volume":"342","author":"N Iida","year":"2013","unstructured":"Iida N, Dzutsev A, Stewart CA et al (2013) Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 342:967\u2013970. doi:10.1126\/science.1240527","journal-title":"Science"},{"key":"1659_CR50","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1126\/science.1240537","volume":"342","author":"S Viaud","year":"2013","unstructured":"Viaud S, Saccheri F, Mignot G et al (2013) The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 342:971\u2013976. doi:10.1126\/science.1240537","journal-title":"Science"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-015-1659-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-015-1659-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-015-1659-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-015-1659-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:03:12Z","timestamp":1744149792000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-015-1659-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,6]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["1659"],"URL":"https:\/\/doi.org\/10.1007\/s00262-015-1659-7","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"type":"print","value":"0340-7004"},{"type":"electronic","value":"1432-0851"}],"subject":[],"published":{"date-parts":[[2015,2,6]]},"assertion":[{"value":"25 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}